CPClaire Hagan Parker

Claire Hagan Parker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claire Hagan Parker has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Longitudinal Trends in Female Representation Among Orthopaedic Residency Programs Most Visible to Potential Applicants, 2005 to 2025

    by Claire H. Parker, Liam J. Edwards-Gaherty, Jeffrey Zhang, Emily H. Stack, Celina Liu, Sydney Q. Laramie, Richelle Fassler, Samantha I. Muhlrad, Brian C. Lynch

    Background: Despite comprising 50.5% of medical students, women remain underrepresented in orthopaedic surgery. As of 2024, orthopaedics had the lowest rate of female residents among surgical specialties at 23.7%. While early exposure programs and signaling have helped promote access, some residencies still match classes without a female resident. Tracking long-term trends in female match rates may highlight opportunities to improve representation. The purpose of this study was to provide longitudinal context for the gender composition of orthopaedic residency programs most visible to applicants by tracking changes in female representation from 2005 to 2025. Methods: We used Doximity’s Residency Navigator to sort programs by perceived reputation, and the programs in the top third results were included in our analysis as these programs are most visible to residency applicants and are presumed to shape applicant perceptions and behavior. Gender composition of interns was collected from program websites and social media for each available year. Weighted linear regression assessed temporal trends; two-proportion Z-tests evaluated regional and urbanicity differences. Results: Among 69 programs, women comprised 23.2% of interns overall. Representation rarely exceeded 20% before 2017, reaching a low of 11.5% in 2006, but surpassed 30% annually since 2022. Female representation increased by 1.2% per year (p < 0.001, R 2 = 0.77). Regional variation persisted, but growth was consistent across geography and program size. Significant increases occurred in metropolitan programs (+18.9%, p < 0.0001) from 2015 to 2025. Conclusion: Female representation at orthopaedic programs most visible on Doximity has risen steadily, with a marked inflection after 2017 and exceeding 30% since 2022. These gains likely reflect combined effects of diversity initiatives, preference signaling, and broader cultural movements advocating gender equity. Future research should examine the impact of signaling on gender diversity and evaluate gender diversity in all orthopaedic residency programs.

  • Comparing oncologic and surgical outcomes of robotic and open pancreatoduodenectomy: an updated meta-analysis

    by Claire H. Parker, Arianna M. Ferretti, Lekha Yaramada, David J. Restle, Shabnam Parsa, Yunhan Liao, Georgios V. Georgakis

    To compare perioperative and oncologic outcomes of robotic pancreaticoduodenectomy (RPD) versus open pancreaticoduodenectomy (OPD) using evidence from cohort studies in a systematic review. This is a systematic review and meta-analysis comparing outcomes between RPD and OPD. Intraoperative outcomes were operative time, estimated blood loss, lymph node yield, R0 resection, and R1 resection. Post-operative outcomes were overall complication rates, Clavien-Dindo ≥ 3, post-operative pancreatic fistula, bile leak, delayed gastric emptying, post-pancreatectomy hemorrhage, wound infection, length of stay, re-admission, re-operation, short-term mortality, and long-term mortality. Fixed-effects model or random-effects model was used to pool results. Heterogeneity was assessed using I2 and Cochran's test. Publication bias was assessed using Egger's test. Influential test, outlier detection, and sensitivity analysis were conducted. Fourteen studies met inclusion criteria, including 2862 patients (1087 in the RPD group and 1775 in the OPD group). The RPD group was associated with longer operative times, less blood loss, lower risk of overall complications, long-term mortality, and short-term mortality, and shorter length of stay. No other significant differences in outcomes were detected between the groups. RPD achieved superior perioperative clinical outcomes and comparable oncologic outcomes. These findings suggest that robotic pancreatoduodenectomy may offer a promising alternative to open surgery.

  • Top Cited Papers
    Open Access

    Glucagon‐like peptide 1 ( GLP ‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials

    by Claire H. Parker, Craig Slattery, Donal J. Brennan, Carel W. le Roux

    Aims: The prevalence of diabetes and obesity continues to rise in women of reproductive age, with significant implications for both mother and foetus. Glucagon‐like peptide‐1 receptor agonists are effective treatments of diabetes and obesity. However, no Glucagon‐like peptide‐1 receptor agonists are currently approved for use during pregnancy. We describe the outcomes of unplanned pregnancies during regulatory clinical trials of Glucagon‐like peptide‐1 receptor agonists submitted to the Food and Drug Administration and European Medicines Agency. Materials and Methods: A search was conducted of the regulatory documentation published by the European Medicines Agency and the Food and Drug Administration on unplanned pregnancies during regulatory clinical trials of Glucagon‐like peptide‐1 receptor agonists. Clinical and Medical Reviews published by the Center for Drug Evaluation and Research at the Food and Drug Administration for every Glucagon‐like peptide‐1 receptor agonist prior to market authorisation were assessed to gather information on unplanned pregnancies that occurred while females were partaking in the clinical development programmes of such drugs. Results: Evidence in women having planned pregnancies is lacking, and the only evidence thus far relies on pregnancies occurring inadvertently during Glucagon‐like peptide‐1 receptor agonist trials. The incidence of congenital abnormalities in humans appears relatively low following Glucagon‐like peptide‐1 receptor agonist use during pregnancy. Conclusions: Key knowledge gaps must be addressed before the introduction of the Glucagon‐like peptide‐1 receptor agonist class of drugs for pregnant women. Currently, Glucagon‐like peptide‐1 receptor agonists should be stopped as soon as the patient becomes aware of a pregnancy. The establishment of patient registries designed to capture data relating to cases of Glucagon‐like peptide‐1 receptor agonist exposure during pregnancy is a high priority, and where data already exist, the findings need to be published.


  • Open Access

    Effect of influenza vaccination on resting metabolic rate and c-reactive protein concentrations in healthy young adults

    by Claire Hagan Parker, Srishti Sadhir, Zane Swanson, Amanda McGrosky, Elena Hinz, Samuel S Urlacher, Herman Pontzer

    Objectives: Chronic immune activation and severe inflammatory states are positively associated with resting metabolic rate (RMR; kcal/day), but the impacts of mild immune stimuli on metabolism are poorly understood. This study investigates the within-individual association between the inflammatory response to influenza vaccination and RMR in young adults. Methods: We evaluated RMRs through indirect calorimetry and circulating c-reactive protein (CRP) concentrations (mg/L)—a direct measure of inflammation—via high-sensitivity immunoassays of dried blood spots (n = 17) at baseline and two- and seven-days post-vaccine. Wilcoxon matched-pairs signed-rank tests were used to evaluate the magnitude of the CRP and RMR responses. Type II Wald chi-square tests of linear mixed-effect models assessed whether those responses were correlated. Results: Baseline CRP was 1.39 ± 1.26 mg/L. On day two post-vaccine, CRP increased by 1.47 ± 1.37 mg/L (p < 0.0001), representing a 106% increase above baseline values. CRP remained higher on day seven post-vaccine, 1.32 ± 2.47 mg/L (p = 0.05) above baseline values. There were no statistically significant changes in RMR from baseline to day two (p = 0.98) or day seven (p = 0.21). Change in CRP from baseline did not predict RMR variation across days (p = 0.46). Conclusions: We find no evidence that adult influenza vaccination results in a corresponding increase in RMR. These results suggest that the energetic cost of an influenza vaccine’s mild inflammatory stimulus is either too small to detect or is largely compensated by a temporary downregulation of energy allocated to other metabolic tasks.


  • Open Access

    PH Roundtable: Transitions in Pulmonary Hypertension

    by Claire Parker, Nancy Bair, Neal Chaisson, Liza Bonpin, Maddie Bonpin

    Claire Parker: Hello. My name is Claire Parker. I’m a nurse practitioner with UCSF Pediatric Pulmonary Hypertension. Today, we’re here to discuss some transitions throughout the lifespan of a pulmonary hypertension patient. We’ve got some wonderful representatives from various PH teams, including a parent and patient. Liza and Maddie, do you want to go ahead and introduce yourself? Maybe, Maddie, you can tell us how old you are and what you’ve been up to?Maddie Bonpin: Hi, I’m Maddie I’m 16 years old. I have PH, and I’ve had it for my entire life.Liza Bonpin: Hi, I’m Maddie’s mom, Liza. I’m Maddie’s super fan since she was born. I can’t believe she’s almost going to be going to college! Nice to be with you all and talk about possible transitions in the near future.Neal Chaisson: My name is Neal Chaisson. I’m an adult pulmonologist and PH provider. I often deal with adolescent transitions because at the Cleveland Clinic, each provider has a specific subset of PH that we specialize in. The primary patient population that I see are patients with congenital heart disease and associated pulmonary hypertension. Obviously, many of these folks transition up through the pediatric cardiology pathway and into our clinic.Nancy Bair: I’m Nancy Bair. I’m the pulmonary hypertension Clinical Nurse Specialist at the Cleveland Clinic with Dr Chaisson and 8 other physicians. I’ve been with the group in PH for about 18 years now.Claire: Wonderful. We’ll start with a question for Liza and Maddie. We would like to know, from your perspective, what is exciting about your transition to adult pulmonary hypertension care and maybe what makes you a little bit nervous or what is unknown about that transition for you?Maddie: I don’t know. I haven’t really thought about it because it’s not really something I’ve thought about with the transition to adult care. I don’t really have anything that I’m excited or nervous about.Liza: Are you excited about almost college?Maddie: Oh, yes, that. I know I’ll be in college in a year and a half.Liza: That’s part of the transition, I think.Maddie: Yes, it is. I’m excited about college because I’m a junior in high school now. I’ll be applying soon.Claire: Maddie, what do you think will be different for you when you come to visits with us versus visits with an adult provider?Maddie: Probably the same thing with different doctors.Claire: Are your parents going to continue to come with you to clinic visits?Liza: It’ll probably just be you, I’m thinking. I’m more than happy to accompany you maybe.Claire: Liza, have you thought about what it will look like with the transition to adult care and more independence for Maddie?Liza: A little bit. We’ve been training with getting to know your meds and knowing what you take and not yet how to order the meds. Just those nitty-gritty details. Then just recently talking about what happens when you’re in college, if you’re living away from home needing to remember to eat right and take your meds. She doesn’t really cook or have any interest in cooking. I know she knows how to buy food, as she said. Having a stable job, which she does have a stable job right now, while at school with income to buy your food if you’re not going to cook it. Not everyone cooks. That’s okay, I told her. Being financially independent as well, which is I think really important. Just knowing how to take care of herself to face herself. That’s still a work in progress, but those are all hopes and concerns that she can be independent and know also when to ask for help and who to ask for help with. It’s exciting. She’s come a long way since 16 years ago. We’re looking forward to it. Obviously, start planning now, start practicing now.Claire: It’s been a long journey with your pediatric providers. It’s going to be a shift, and it’s going to be different. I can tell you from a pediatric provider perspective, we’re so excited for when we’re able to transition some of our patients to the adult group, and it almost feels like we’re bringing you towards graduation. We are both excited and nervous for you to be more independent. Sometimes it’s a little hard even for your providers to deal with that transition knowing that we won’t be involved in your medical care moving forward. Neal, what challenges do you see when young adults transition into your practice?Neal: I think back to 2 recent experiences, and I think Nancy has worked with me on both of these patients. One patient came of age to transition and was encouraged by her mom to become more independent, but was very scared to leave the nest, if you will. This wasn’t a bad thing, but she emphasized to me the need to be patient and help her make the transition from dependence on her parents to independence on her terms. Many pediatric pulmonary hypertension patients have travelled this journey shoulder to shoulder with their parents, especially when they’re on IV therapies. So navigating things can be a real challenge. We had to really sit down with my patient and establish goals together. Sometimes they worked, and sometimes we had to regroup and provide reassurance and another shot at boosting her confidence.On the flip side, I had another patient with idiopathic pulmonary arterial hypertension since age 4 who transitioned easily. This individual went to college and insisted on being so independent that they just decided the medications weren’t necessary. This obviously created some issues for him. Regrouping and helping his parents to rebuild trust in their son was a challenge. I think that the smoothest transitions occur when we help families, parents and patients alike, to anticipate and discuss what a...